Abdullah Alekuzei(主管Naumann博士)Dominik Baku(主管PD Mengel博士)Sinan Barus(主管Ziemann教授)Mark Divkovic(Ziemann博士)Mark Divkovic(Poli. Poli教授Poli)SaraDörre教授SaraDörre(Ziemann博士) Ziemann博士)佩德罗·戈登(Pedro Gordon)教授(Ziemann博士教授)帕特里夏·亨宁(Patricia Henning)(主管Poli教授)Xinchen Hui(主管Poli教授Poli)Dania Humaidan(Ziemann博士Ziemann教授)Gongfei Li(主管PD Merjam Lingel)Mirjam Lingel Lingel Pd博士(Merkel)Merkel Lingel Pd Merkel(Merkel)Merkel lusor lu lu lu lu, Prof. Dr. Naumann) Saskia Rabe (Supervisors Dr. Pomper, Prof. Dr. Uwe Ilg) Hardy Richter (Supervisor Prof. Dr. Poli) Jakob Rüttinger (Supervisor Prof. Dr. Naumann) Pauline Schneider (Supervisor PD Dr. Mengel) Constanze Single (Supervisors PD Dr. Feil, PD Dr. Mengel) Linda Shifunje (Supervisor PD Dr. Kowarik)Elina Song(主管Ziemann教授)夏洛特·斯宾塞(夏洛特·斯宾塞(Poli. poli教授)安妮卡·斯皮尔曼(Annika Spielmann)(主管Ziemann教授)CatrinaThönnes(主管PD PD Mengel博士) (主管Poli博士)Abdullah Alekuzei(主管Naumann博士)Dominik Baku(主管PD Mengel博士)Sinan Barus(主管Ziemann教授)Mark Divkovic(Ziemann博士)Mark Divkovic(Poli. Poli教授Poli)SaraDörre教授SaraDörre(Ziemann博士) Ziemann博士)佩德罗·戈登(Pedro Gordon)教授(Ziemann博士教授)帕特里夏·亨宁(Patricia Henning)(主管Poli教授)Xinchen Hui(主管Poli教授Poli)Dania Humaidan(Ziemann博士Ziemann教授)Gongfei Li(主管PD Merjam Lingel)Mirjam Lingel Lingel Pd博士(Merkel)Merkel Lingel Pd Merkel(Merkel)Merkel lusor lu lu lu lu, Prof. Dr. Naumann) Saskia Rabe (Supervisors Dr. Pomper, Prof. Dr. Uwe Ilg) Hardy Richter (Supervisor Prof. Dr. Poli) Jakob Rüttinger (Supervisor Prof. Dr. Naumann) Pauline Schneider (Supervisor PD Dr. Mengel) Constanze Single (Supervisors PD Dr. Feil, PD Dr. Mengel) Linda Shifunje (Supervisor PD Dr. Kowarik)Elina Song(主管Ziemann教授)夏洛特·斯宾塞(夏洛特·斯宾塞(Poli. poli教授)安妮卡·斯皮尔曼(Annika Spielmann)(主管Ziemann教授)CatrinaThönnes(主管PD PD Mengel博士) (主管Poli博士)
1。Purpose .............................................................................................................................................................................. 1 2.Scope and Key Terms ........................................................................................................................................................ 1 3.Contact Information .......................................................................................................................................................... 1 3.1.紧急情况(如果使用内部ASU手机,请记住拨打9的外线).................................................................................................................................. 1 3.2。Non-Emergencies ...................................................................................................................................................... 1 4.Culture of Safety ............................................................................................................................................................... 1 5.Record Retention ............................................................................................................................................................... 2 6.Training ............................................................................................................................................................................. 2 7.Bloodborne Pathogens and Training ................................................................................................................................. 2 8.遏制。Responsibilities and Authority .......................................................................................................................................... 3 8.1.Departments ............................................................................................................................................................... 3 8.2.Laboratory Supervisors ............................................................................................................................................. 3 8.3.Laboratory Personnel (Including Students) ............................................................................................................... 4 8.4.Principal Investigator (Research Settings) ................................................................................................................. 4 8.5.Environmental Safety, Health, and Risk Management (EHSRM) ............................................................................. 5 9.Principles of Biosafety ...................................................................................................................................................... 5 9.1.............................................................................................................................................................. 5 9.2.Primary and Secondary Containment ........................................................................................................................ 5 9.3.Elements of Containment .......................................................................................................................................... 5 9.4.Hazard Assessment .................................................................................................................................................... 6 10.General Biosafety Guidelines for Infectious Agents ......................................................................................................... 6
Key responsibilities for managers include the following: • Identifying the best way to get front-line workers across shifts trained • Communicating the purpose, objective, value, and project plan for the implementation • Ensuring that their supervisors attend the modules • Providing time for front-line workers to attend training modules • Reinforcing messages from each module as they occur • Integrating seeing, thinking, doing, moving, and teaming prompts into safety activities • Reinforcing sustainment activities •回应成功案例•认识前线工人应用策略•利用视觉提醒•测量进度的主要指标
Steve Sandy – 县行政助理 Carrie Spencer – 社区发展总监 Lisa Cooper – 规划总监 Mindy Goldsmith – 行政助理 II Sherrie Mitchell – 富兰克林县规划委员会主席、Snow Creek 区 Deborah Crawford – 富兰克林县规划委员会副主席、Union Hall 区 David Clements – 富兰克林县规划委员会成员、Rocky Mount 区 CW Doss, Jr. – 富兰克林县规划委员会成员、Blue Ridge 区 Cheryl Ege – 富兰克林县规划委员会成员、Gills Creek 区 Angie McGhee – 富兰克林县规划委员会成员、Boone 区 David Pendleton – 富兰克林县规划委员会成员、Blackwater 区 Ronnie Thompson – 富兰克林县监事会主席、Boone 区 Tim Tatum – 富兰克林县监事会副主席、Blue Ridge 区 Mike Carter – 富兰克林县监事会成员、Rocky Mount 区 Tommy Cundiff – 富兰克林县监事会成员、Union Hall 区 Leland Mitchell – 富兰克林县监事会,Snow Creek 区 Ronald Mitchell – 成员,富兰克林县监事会,Blackwater 区 Lorie Smith – 成员,富兰克林县监事会,Gills Creek 区
通过研究促进和维持干细胞命运主管的网络来控制垂体的再生潜力的因素:Cynthia andoniaDou KCl,TBA TUD 4。Maria Alejandra Ramirez Torres成熟机制的人类多能干细胞衍生的胰岛(SC- iSlets)主管:Anthony Gavalas Tud,Francesca Spagnoli KCl 5。Maria Cristina Garrone使用患者衍生的诱导性干细胞对先天性高胰岛素主管进行建模:Rocio Sancho KCL,Anne Grapin-Botton Tud 6。Olivia Sherwin应力对垂体干细胞主管的影响:Cynthia andoniadou Kcl,Charlotte Steenblock&Steefan Bornstein Tud 7。panagiota siatra在应力适应主管期间研究了HPA轴的茎和祖细胞的可塑性:Charlotte Steenblock&Steefan Bornstein Tud,Cynthia andoniadou Kcl 8。Anna Salkowa细胞命运在人类胰腺B细胞开发主管期间的决定:Francesca Spagnoli KCl,TBA TUD 9。Jenny Gehlen建立合成PEG水凝胶系统,以研究生化和机械的细胞外提示如何影响胰腺器官主管中的细胞命运决策:Rocio Sancho KCl,TBA TUD TUD
4。panagiota siatra在压力适应主管期间研究了HPA轴的茎和祖细胞的可塑性:夏洛特·斯特恩布洛克和斯特凡·伯恩斯坦·托德,辛西娅·安东尼·尼迪亚德·KCl 5。Maria Alejandra Ramirez Torres成熟机制的人类多能干细胞衍生的胰岛(SC- iSlets)主管:Anthony Gavalas Tud,Francesca Spagnoli Kcl 6。IREM辅助瘦素和瘦素受体信号传导中的糖尿病心肌病主管:Kaomei Guan Tud,Cynthia andoniadou&geltrude mingrone kcl 7。心血管和代谢性疾病主管中心脏和免疫细胞串扰内的Anindita dhara natriate肽信号传导:SusanneKämmerer:Ali El-Armarouche Tud,Barbara McGowan,Manuel Mayr Mayr Kcl 8。dipanjana dolui系统生物学方法在兰格汉胰岛在代谢和糖尿病主管中的作用中的性别差异方法:斯蒂芬·斯皮尔·图(Stephan Speier Tud),彼得·琼斯(Peter Jones KCl),彼得·琼斯KCL 12:35-13:30
Inside Cover Important Notice 2 Company's Basic Information 10 Chairman's Statement 15 Summary of Accounting Data 16 Management Discussion and Analysis 44 Significant Events 50 Changes in Equity and Shareholders' Information 56 Corporate Bonds 59 Directors, Supervisors and Senior Management 69 Corporate Governance Report 123 Directors' Report 167 Report of Supervisory Committee 170 Independent Auditor's Report 178 Consolidated Balance Sheet 180 Consolidated Income Statement 181 Consolidated Statement of Comprehensive Income 182股权变更的合并声明184合并现金流量声明186合并财务报表的注释312五年财务摘要
正在监督上述许可的个人可以继续担任主管,而无需满足批准的临床主管的新要求,直到2027年1月1日。在该日期之后,个人必须遵守临床主管继续提供监督服务的要求。
